Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Radiolabeled Normosol-R is a modified version of standard Normosol-R solution that has been tagged with a radioisotope for research or diagnostic purposes. The base solution is a sterile, nonpyrogenic isotonic solution of balanced electrolytes in water for injection. It contains sodium chloride, sodium acetate, sodium gluconate, potassium chloride, and magnesium chloride hexahydrate. The electrolyte composition closely mimics that of normal plasma, making it suitable for replacement of acute extracellular fluid losses without disturbing normal electrolyte relationships. The radiolabeled version allows for tracking the solution's distribution and absorption in research settings.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on radiolabeled normosol-r.